​

Palvella Therapeutics Ownership | Who Owns Palvella Therapeutics?

OverviewChart

Palvella Therapeutics Ownership Summary

Palvella Therapeutics is owned by 230.20% institutional investors, 17.50% insiders.

PVLA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPalvella Therapeutics230.20%17.50%-147.70%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254021.21%5,124,16727.05%2300.70%2471.43%4-33.33%
Dec 31, 20243337.50%4,033,115565.98%18124.48%1440.00%6-
Sep 30, 20242426.32%605,59167.17%2710.27%10-47.37%6-
Jun 30, 202419-362,269-16-19---

Recent Insider Transactions

DateNameRoleActivityValue
Apr 09, 2025JENKINS GEORGE M-Buy$50.33K
Apr 09, 2025JENKINS GEORGE M-Buy$50.47K
Dec 18, 2024JENKINS GEORGE M-Buy$51.72K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q41-

PVLA Ownership FAQ

Who Owns Palvella Therapeutics?

Palvella Therapeutics shareholders are primarily institutional investors at 230.20%, followed by 17.50% insiders and -147.70% retail investors. The average institutional ownership in Palvella Therapeutics's industry, Biotech Stocks , is 63.84%, which Palvella Therapeutics exceeds.

Does Blackrock own Palvella Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Palvella Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools